Projecting the Impact of Covid-19 Variants and Vaccination Strategies in Disease Transmission using a Multilayer Network Model in Costa Rica
Yury E. Garc\'ia, Gustavo Mery, Paola V\'asquez, Juan G. Calvo, Luis, A. Barboza, Tania Rivas, Fabio Sanchez

TL;DR
This study uses a multilayer network model to forecast Covid-19 transmission in Costa Rica, assessing the impact of the Delta variant and vaccination strategies on hospitalizations and ICU admissions.
Contribution
It introduces a multilayer network model to simulate Covid-19 spread and evaluate vaccination scenarios and variant impacts in Costa Rica.
Findings
Delta variant increases hospitalizations by up to 35%
Slower vaccination pace leads to 27% more ICU admissions
Maintaining high vaccination rates mitigates variant impact
Abstract
For countries starting to receive steady supplies of vaccines against SARS-CoV-2, the course of Covid-19 for the following months will be determined by the emergence of new variants and successful roll-out of vaccination campaigns. To anticipate this scenario, we used a multilayer network model developed to forecast the transmission dynamics of Covid-19 in Costa Rica, and to estimate the impact of the introduction of the Delta variant in the country, under two plausible vaccination scenarios, one sustaining Costa Rica's July 2021 vaccination pace of 30,000 doses per day and with high acceptance from the population and another with declining vaccination pace to 13,000 doses per day and with lower acceptance. Results suggest that the introduction and gradual dominance of the Delta variant would increase Covid-19 hospitalizations and ICU admissions between and , from August…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 epidemiological studies · SARS-CoV-2 and COVID-19 Research · Vaccine Coverage and Hesitancy
